Yunjiao Zhou
Overview
Explore the profile of Yunjiao Zhou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
1209
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yang Z, Zhou Y, Xie L, Yang J
IEEE Trans Cybern
. 2025 Mar;
PP.
PMID: 40030406
The 3-D point cloud has been widely used in many mobile application scenarios, including autonomous driving and 3-D sensing on mobile devices. However, existing 3-D point cloud models tend to...
2.
Yao H, Tong W, Song Y, Li R, Xiang X, Cheng W, et al.
J Neuroinflammation
. 2024 Sep;
21(1):246.
PMID: 39342308
The primary pathological change in Parkinson's disease (PD) is the progressive degeneration of dopaminergic neurons in the substantia nigra. Additionally, excessive microglial activation and synaptic loss are also typical features...
3.
Jia Z, Wang K, Xie M, Wu J, Hu Y, Zhou Y, et al.
Protein Cell
. 2024 May;
15(12):930-937.
PMID: 38801319
No abstract available.
4.
Wu J, Chen Z, Gao Y, Wang Z, Wang J, Chiang B, et al.
Cell Rep
. 2023 May;
42(5):112503.
PMID: 37178120
Striking antibody evasion by emerging circulating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants drives the identification of broadly neutralizing antibodies (bNAbs). However, how a bNAb acquires increased neutralization breadth...
5.
Xie M, Zhu Y, Zhou Y, Wang Q, Gu E, Chu Y, et al.
Cell Death Discov
. 2023 Feb;
9(1):67.
PMID: 36797242
Interleukin-35 (IL-35)-producing B cells (IL-35B cells) play an important role in diseases, and the expansion of IL-35 immune cells have been observed in inflammatory bowel disease (IBD). However, how IL-35B...
6.
Li S, Wu J, Jiang W, He H, Zhou Y, Wu W, et al.
J Med Virol
. 2022 Dec;
95(2):e28440.
PMID: 36573441
Emergence of various circulating SARS-CoV-2 variants of concern (VOCs) promotes the identification of pan-sarbecovirus vaccines and broadly neutralizing antibodies (bNAbs). Here, to characterize monoclonal antibodies cross-reactive against both SARS-CoV-1 and...
7.
Wu J, Chen Z, Gao Y, Wang Z, Wang J, Chiang B, et al.
bioRxiv
. 2022 Dec;
PMID: 36561175
Striking antibody evasion by emerging circulating SARS-CoV-2 variants drives the identification of broadly neutralizing antibodies (bNAbs). However, how a bNAb acquires increased neutralization breadth during antibody evolution is still elusive....
8.
Wang L, Fu W, Bao L, Jia Z, Zhang Y, Zhou Y, et al.
Cell Res
. 2022 Jun;
32(7):691-694.
PMID: 35672388
No abstract available.
9.
Wang K, Jia Z, Bao L, Wang L, Cao L, Chi H, et al.
Nature
. 2022 Jan;
603(7903):919-925.
PMID: 35090164
Omicron (B.1.1.529), the most heavily mutated SARS-CoV-2 variant so far, is highly resistant to neutralizing antibodies, raising concerns about the effectiveness of antibody therapies and vaccines. Here we examined whether...
10.
Zhou Y, Yang Z, Zhang H, Li H, Zhang M, Wang H, et al.
Biochim Biophys Acta Mol Basis Dis
. 2022 Jan;
1868(4):166353.
PMID: 35063646
The inactivation of tumor suppressor DOC-2/DAB2 interactive protein (DAB2IP) by epigenetic and post-transcriptional modification has been reported in multiple human malignancies. DNA methyltransferase 3A (DNMT3A) is involved in de novo...